ZTS Zoetis Inc
Price (delayed)
$148.67
Market cap
$66.57B
P/E Ratio
27.18
Dividend/share
$1.8
EPS
$5.47
Enterprise value
$71.33B
Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's
Highlights
The P/E is 33% lower than the 5-year quarterly average of 39.8 and 19% lower than the last 4 quarters average of 33.2
The gross profit has grown by 9% YoY
Zoetis's quick ratio has decreased by 47% QoQ and by 45% YoY
ZTS's equity is down by 9% since the previous quarter and by 4.5% year-on-year
Key stats
What are the main financial stats of ZTS
Market
Valuations
Earnings
Shares outstanding
447.79M
Market cap
$66.57B
Enterprise value
$71.33B
Price to earnings (P/E)
27.18
Price to book (P/B)
14.06
Price to sales (P/S)
7.3
EV/EBIT
21.31
EV/EBITDA
18.55
EV/Sales
7.71
Revenue
$9.26B
Gross profit
$6.54B
Operating income
$3.36B
Net income
$2.49B
EBIT
$3.35B
EBITDA
$3.85B
Free cash flow
$2.3B
Per share
Balance sheet
Liquidity
EPS
$5.47
EPS diluted
$5.47
Free cash flow per share
$5.06
Book value per share
$10.57
Revenue per share
$20.38
TBVPS
$22.87
Total assets
$14.24B
Total liabilities
$9.47B
Debt
$6.74B
Equity
$4.77B
Working capital
$2.57B
Debt to equity
1.41
Current ratio
1.75
Quick ratio
0.97
Net debt/EBITDA
1.24
Margins
Efficiency
Dividend
EBITDA margin
41.5%
Gross margin
70.6%
Net margin
26.9%
Operating margin
36.3%
Return on assets
17.4%
Return on equity
49.7%
Return on invested capital
25.6%
Return on capital employed
30.9%
Return on sales
36.2%
Dividend yield
1.21%
DPS
$1.8
Payout ratio
32.8%
ZTS stock price
How has the Zoetis stock price performed over time
Intraday
1.3%
1 week
1.14%
1 month
-9.99%
1 year
-2.15%
YTD
-8.75%
QTD
-9.71%
Financial performance
How have Zoetis's revenue and profit performed over time
Revenue
$9.26B
Gross profit
$6.54B
Operating income
$3.36B
Net income
$2.49B
Gross margin
70.6%
Net margin
26.9%
The gross profit has grown by 9% YoY
ZTS's revenue is up by 8% YoY
Zoetis's operating income has increased by 6% YoY and by 2.3% QoQ
The net income has grown by 6% YoY and by 2.3% from the previous quarter
Growth
What is Zoetis's growth rate over time
Valuation
What is Zoetis stock price valuation
P/E
27.18
P/B
14.06
P/S
7.3
EV/EBIT
21.31
EV/EBITDA
18.55
EV/Sales
7.71
The P/E is 33% lower than the 5-year quarterly average of 39.8 and 19% lower than the last 4 quarters average of 33.2
Zoetis's EPS has increased by 8% YoY and by 2.6% QoQ
The stock's price to book (P/B) is 24% less than its 5-year quarterly average of 18.3 and 13% less than its last 4 quarters average of 15.9
ZTS's equity is down by 9% since the previous quarter and by 4.5% year-on-year
ZTS's price to sales (P/S) is 31% lower than its 5-year quarterly average of 10.4 and 19% lower than its last 4 quarters average of 8.9
ZTS's revenue is up by 8% YoY
Efficiency
How efficient is Zoetis business performance
ZTS's ROIC is up by 4.5% QoQ and by 4.5% YoY
ZTS's return on assets is up by 3.6% year-on-year and by 2.4% since the previous quarter
The company's return on equity rose by 3.5% QoQ
Zoetis's return on sales has decreased by 2.7% YoY
Dividends
What is ZTS's dividend history
DPS
$1.8
Dividend yield
1.21%
Payout ratio
32.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Zoetis financials performed over time
ZTS's total assets is 50% greater than its total liabilities
The company's current ratio has shrunk by 53% QoQ and by 48% YoY
Zoetis's quick ratio has decreased by 47% QoQ and by 45% YoY
The debt is 41% higher than the equity
Zoetis's debt to equity has increased by 9% QoQ and by 4.4% YoY
ZTS's equity is down by 9% since the previous quarter and by 4.5% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.